Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Calcilytix Therapeutics Inc.
Sponsor

Calcilytix Therapeutics Inc.

United States 1800 Owens Street Suite C1200, 94158-2381, United States

About the sponsor

Calcilytix Therapeutics Inc. focuses on Autosomal Dominant Hypocalcemia Type 1 (ADH1), a rare disorder affecting calcium regulation and parathyroid hormone signaling. Its clinical activity is centered on correcting abnormalities in blood calcium and urinary calcium excretion.

  • Hypocalcemia management
  • Parathyroid hormone receptor biology
  • Calcium balance

The sponsor’s research interest is concentrated on therapies for inherited disorders of mineral metabolism.

About Specializations

Calcilytix Therapeutics Inc. runs clinical trials in conditions such as Hypocalcaemia, among others.

All trials

Ongoing trials

Clinical trials registered by this sponsor – none is enrolling right now.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

1 clinical trial

Hypocalcaemia

Not recruiting
Registered drugNo placebo
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Alfacalcidol
  • Sponsor:Calcilytix Therapeutics Inc.

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Join now →
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.